High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2)

被引:6
|
作者
LeSarge, Jordan C. [1 ]
Thibeault, Pierre [2 ]
Milne, Mark [5 ]
Ramachandran, Rithwik [2 ]
Luyt, Leonard G. [1 ,3 ,4 ,5 ]
机构
[1] Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 3K7, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, Dept Oncol, 1151 Richmond St, London, ON N6A 3K7, Canada
[4] Univ Western Ontario, Dept Med Imaging, 1151 Richmond St, London, ON N6A 3K7, Canada
[5] Lawson Hlth Res Inst, London Reg Canc Program, 800 Commissioners Rd East, London, ON N6A 5W9, Canada
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2019年 / 10卷 / 07期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Proteinase-activated receptor 2 (PAR2); peptide; targeted fluorescent probes; fluorescence imaging; structure-activity relationship; MOLECULAR-CLONING; EXPRESSION; POTENT; BINDING; PROTEASE-ACTIVATED-RECEPTOR-1; 2-FUROYL-LIGRLO-AMIDE; AGONISTS; PEPTIDE; GROWTH; CANCER;
D O I
10.1021/acsmedchemlett.9b00094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
PAR2 is a proteolytically activated G protein coupled receptor (GPCR) that is implicated in various cancers and inflammatory diseases. Ligands with low nano molar affinity for PAR2 have been developed, but there is a paucity of research on the development of PAR2-targeting imaging probes. Here, we report the development of seven novel PAR2-targeting compounds. Four of these compounds are highly potent and selective PAR2-targeting peptides (EC50 = 10 to 23 nM) that have a primary amine handle available for facile conjugation to various imaging components. We describe a peptide of the sequence Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 as the most potent and highest affinity PAR2-selective fluorescent probe reported to date (EC50 = 16 nM, K-D = 38 nM). This compound has a greater than 10-fold increase in potency and binding affinity for PAR2 compared to the leading previously reported probe and is conjugated to a red-shifted fluorophore, enabling in vitro and in vivo studies.
引用
收藏
页码:1045 / 1050
页数:11
相关论文
共 50 条
  • [21] Proteinase-activated receptor 2 is involved in the behavioural changes associated with sickness behaviour
    Abulkassim, Roua
    Brett, Ros
    MacKenzie, Scott M.
    Bushell, Trevor J.
    JOURNAL OF NEUROIMMUNOLOGY, 2016, 295 : 139 - 147
  • [22] Role of Matriptase and Proteinase-Activated Receptor-2 in Nonmelanoma Skin Cancer
    Bocheva, Georgeta
    Rattenholl, Anke
    Kempkes, Cordula
    Goerge, Tobias
    Lin, Chen-Yong
    D'Andrea, Michael R.
    Staender, Sonja
    Steinhoff, Martin
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (07) : 1816 - 1823
  • [23] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [24] Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells
    Kaufmann, Roland
    Mussbach, Franziska
    Henklein, Petra
    Settmacher, Utz
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (06) : 965 - 973
  • [25] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09) : 2003 - 2022
  • [26] Proteinase-Activated Receptor-2 in the Pathogenesis of Gastroesophageal Reflux Disease
    Kandulski, Arne
    Wex, Thomas
    Moenkemueller, Klaus
    Kuester, Doerthe
    Fry, Lucia C.
    Roessner, Albert
    Malfertheiner, Peter
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (09) : 1934 - 1943
  • [27] Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
    Witte, David
    Zeeh, Franziska
    Gaedeken, Thomas
    Gieseler, Frank
    Rauch, Bernhard H.
    Settmacher, Utz
    Kaufmann, Roland
    Lehnert, Hendrik
    Ungefroren, Hendrik
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (12):
  • [28] The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion
    Fujimoto, Daisuke
    Hirono, Yasuo
    Goi, Takanori
    Katayama, Kanji
    Matsukawa, Shigeru
    Yamaguchi, Akio
    BMC CANCER, 2010, 10
  • [29] Pathway-selective antagonism of proteinase activated receptor 2
    Suen, J. Y.
    Cotterell, A.
    Lohman, R. J.
    Lim, J.
    Han, A.
    Yau, M. K.
    Liu, L.
    Cooper, M. A.
    Vesey, D. A.
    Fairlie, D. P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (17) : 4112 - 4124
  • [30] Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer
    Elste, Andrea Pia
    Petersen, Iver
    JOURNAL OF MOLECULAR HISTOLOGY, 2010, 41 (2-3) : 89 - 99